In contrast, our second hit from the screens, JOSD2, was only altered in 5% of breast cancer cases and was not associated with survival or with KIFC1 protein levels (Appendix Fig. S4), so was not investigated further. This evidence concerns the gene JOSD2 and breast carcinoma.